Compare MOVE & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOVE | SRZN |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.4M | 271.6M |
| IPO Year | 2021 | 2020 |
| Metric | MOVE | SRZN |
|---|---|---|
| Price | $10.83 | $17.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | ★ 299.3K | 169.9K |
| Earning Date | 04-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $433,000.00 | ★ $3,477,000.00 |
| Revenue This Year | $1,460.71 | $75.35 |
| Revenue Next Year | $96.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.52 | $11.35 |
| 52 Week High | $34.87 | $35.00 |
| Indicator | MOVE | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 25.28 |
| Support Level | $7.52 | $17.44 |
| Resistance Level | $12.08 | $23.90 |
| Average True Range (ATR) | 1.74 | 1.39 |
| MACD | -0.04 | -0.58 |
| Stochastic Oscillator | 22.17 | 8.03 |
Corvex Inc is an AI cloud computing company that provides computing infrastructure for artificial intelligence workloads, including GPU-accelerated computing, confidential computing, and inference services. Its offerings are used by government and enterprise customers, including those with regulated workloads, to support the deployment and operation of AI models and data processing systems. The company generates revenue from the sale of Wellness Rings, portable chargers and charging cables, ring sizers, and mobile applications.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).